Seven TRI oscillations were observed in the IMS-anti-PD-1/TMZ and IMS-anti-PD-1 treated mice and these were generally coincident with stable disease (SDi) and partial response (Pre) tumour stages (Table S1), according to the adapted Response Evaluation Criteria in Solid Tumours (RECIST) criteria. This evidence concerns the gene PDCD1 and neoplasm.